Pembro +/- Chemo Confirmed Established 1st-line SoC for Recurrent/Metastatic H&N Squamous Cell Carcinoma with Improved OS and Favorable Safety Profile

313 views
January 7, 2020
Comments 0
Login to view comments. Click here to Login